Pavlova, S.V.; Shulgina, A.E.; Zakian, S.M.; Dementyeva, E.V.
Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells. Int. J. Mol. Sci. 2024, 25, 8695.
https://doi.org/10.3390/ijms25168695
AMA Style
Pavlova SV, Shulgina AE, Zakian SM, Dementyeva EV.
Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells. International Journal of Molecular Sciences. 2024; 25(16):8695.
https://doi.org/10.3390/ijms25168695
Chicago/Turabian Style
Pavlova, Sophia V., Angelina E. Shulgina, Suren M. Zakian, and Elena V. Dementyeva.
2024. "Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells" International Journal of Molecular Sciences 25, no. 16: 8695.
https://doi.org/10.3390/ijms25168695
APA Style
Pavlova, S. V., Shulgina, A. E., Zakian, S. M., & Dementyeva, E. V.
(2024). Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells. International Journal of Molecular Sciences, 25(16), 8695.
https://doi.org/10.3390/ijms25168695
